Endocrine Abstracts

Rajesh Thakker is the May Professor of Medicine at the University of Oxford, UK. He received his medical degree from the University of Cambridge in 1980, and from 1981 to 1988 he undertook postgraduate clinical and research training at The Middlesex Hospital, The Hammersmith (Royal Postgraduate Medical School, RPMS), Hospital, and Northwick Park (MRC Clinical Research Centre) Hospital (London). In 1988, he was appoint...

Dr Richard J Auchus is Professor of Pharmacology and Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan and Director of the Diabetes, Endocrinology, & Metabolism Fellowship Program at Michigan. He did postdoctoral work and training at the University of California, San Francisco prior to joining the faculty at UT Southwestern in Dallas. He served as Acting Chi...

Objective: Journal of Molecular Endocrinology)-->Recent advances in next-generation sequencing (NGS) technology have permitted comprehensive genomic characterization of the most common types of cancer. The Cancer Genome Atlas (TCGA), a program of the U.S. National Institutes of Health (a joint NCI and NHGRI effort), was created to systematically analyze the genome of the most common types of cancer, inclu...

Endorsed by the European Journal of Endocrinology )-->Central neck dissection for papillary thyroid cancer (PTC) was initially proposed by Scandinavian authors in the late 70’s on the following grounds: i) the common presence of obvious metastatic nodal disease in compartment VI; ii) compartment VI is the first step in lymph node dissemination of PTC; and iii) prevents cancer recurrence in the ce...

Introduction: Hyponatraemia is the commonest electrolyte disorders encountered in hospitals. The aetiology of hyponatraemia is based on clinic assessment and biochemical investigations. However, studies have shown that recommended guidelines are usually not implemented.Aim: Review of assessment (diagnosis) of Hyponatraemia and outcome based on length of stay (LOS) in hospitals.Methods: A systematic search using PUB Med and Med Line...

Introduction: Systemic glucocorticoid therapy may put patients at risk for later adrenal failure during times of stress, but tapering increases cumulative steroid exposure. We prospectively evaluated adrenal function and clinically relevant hypocortisolism after abruptly stopping prednisone treatment in patients with exacerbated COPD.Methods: This is a pre-specified analysis of the REDUCE randomized trial (Journal of American Medical Association...

Decrum’s disease or adiposis dolorasa is a rare progressive syndrome of unknown aetiology. It is characterised by painful fatty deposits, general obesity, weakness and unexplained emotional disturbance.1We describe a case of a 55-year-old man who presented with pneumonia. On examination he was noted to be overweight and have multiple skin nodules. His chest X-ray was abnormal; he underwent further workup with a CT thorax/abdomen/pelvis. T...

The fractures that result from postmenopausal osteoporosis have a major public health impact. We have a number of drugs we can use to reduce the risk of these fractures. Most of these drugs are anti-resorptive, such as the bisphosphonates (alendronate, ibandronate, risedronate and zoledronate), raloxifene, oestrogen, and denosumab. Until recently the only anabolic agent available was teriparatide. However, in the last couple of years two new agents have been approved in some c...

Von Hippel–Lindau (VHL) disease, attributable to germline mutations in the VHL gene on the short arm of chromosome 3 (3p25-26) is an inherited condition which can give rise to paragangliomas. We present a case of 47 year old gentleman with bilateral pheochromocytomas in the past resulting in both adrenalectomies as a child in the 1980. His routine follow up subsequently picked up elevated urine Normetanephrines at 14.3 µmol/24 h 25 years postoperatively. His CT abdo...

Cortisol has a distinct circadian rhythm; levels rise from 0300 h to peak within an hour of waking and gradually decline until 1800 h before a quiescent period lasting from 1800 to 0300 h. Current hydrocortisone replacement regimens are unable to replicate this rhythm and we have been investigating modified release technology. Our initial formulation, using tableting technology, demonstrated it was possible to replicate the overnight rise in cortisol but the tablet had reduced...